According to EuropeanPharmaceuticalReview.com, researchers concluded a 15-year study on cholesterol-lowering statin medications. In the study, which was published in the British Journal of Clinical Pharmacology, patients who are prescribed statin medications may be “at a higher risk for developing high blood sugar levels, insulin resistance, and eventually type 2 diabetes.”
The Rotterdam study included 9,535 study participants who were over the age of 45 and who were not diabetic. The study’s participants were followed up with and given medical examinations over a 15-year period. The study’s analysis found that patients who use statin drugs had insulin resistance and had increased concentrations of serum fasting insulin than those study participants who were not taking statin medications. The study concluded that participants taking cholesterol-lowering statin drugs “had a 38 percent higher risk of developing type 2 diabetes.” The study also found that the risk for developing type 2 diabetes was even greater for those participants who were overweight and had an impaired glucose balance.
According to Professor Bruno Stricker, from the Erasmus Medical Centre located in the Netherlands, “The findings suggest that in patients who initiate statin therapy, preventive strategies such as blood sugar control and weight loss may be warranted for minimizing the risk of diabetes.”
Although this study reported the type 2 diabetes risk was 12 percent higher than in other randomized clinical trials, the researchers in the study were careful to point out that this study did not positively conclude that statins caused the increased risk of diabetes.
Statins: A History of Serious Complications and Side Effects
Cholesterol-lowering statin medications have a long history of serious side effects and health risks.
In February of 2012, the U.S. Food and Drug Administration reported that statin medications had been linked to an increased risk of Diabetes Mellitus prompting thousands of lawsuits to be filed against certain statin manufacturers.
In April of 2013, one of the largest statin medication class action lawsuits was filed in the U.S. District Court of South Carolina. The class action lawsuit was filed against Pfizer, the maker of Lipitor. The lawsuit alleged that Pfizer’s popular statin medication, Lipitor, did not include adequate warnings about the drug’s increased type 2 diabetes risks.
Do You Have a Claim?
Were you or a family member prescribed one of the following cholesterol-lowering statin medications and developed type 2 diabetes?
- Altoprev (lovastatin extended-release);
- Crestor (rosuvastatin);
- Lescol (fluvastatin);
- Lipitor (atorvastatin);
- Mevacor (lovastatin);
- Pravachol (pravastatin);
- or Zocor (simvastatin).
Parker Waichman LLP is a national products liability law firm, and our attorneys have recovered over $2 BILLION in verdicts and settlements for victims of defective drugs, dangerous products, and serious personal injuries. Our law firm is currently reviewing cases of possible statin-related type 2 diabetes. If you or a loved one has been prescribed a cholesterol-lowering statin medication and developed type 2 diabetes, our firm may be able to take your case and help you recover full monetary compensation for your injuries.
Time is limited to file your claim, so contact our firm right away. Call Parker Waichman LLP to find out more about your potential claim. Simply use our Live Chat or call 1-800-YOURLAWYER (1-800-968-7529) for your free case analysis with one of our experienced attorneys.
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation
Do you have type 2 diabetes and are prescribed a statin medication?